Cite
HARVARD Citation
Agalliu, I. et al. (2019). Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls. Movement disorders. 34 (9), pp. 1392-1398. [Online].